Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.2900
+0.0150 (5.45%)
Nov 9, 2026, 10:47 AM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $11.83 million as of November 9, 2026. It is the 40,660th most valuable company in the world and the 5,499th biggest in the United States. Its market cap has decreased by 88.10% in one year.
Market Cap
11.83M
Enterprise Value
2.79M
Revenue
n/a
Global Rank
Country Rank
#5,499 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 11.83M, a decrease of -92.84%. That is a compound annual growth rate of -38.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 11.83M | -71.50% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 19.41M |
| Vicapsys Life Sciences | 16.19M |
| Inhibitor Therapeutics | 13.73M |
| Synlogic | 13.47M |
| Brainstorm Cell Therapeutics | 12.83M |
| Hepion Pharmaceuticals | 12.01M |
| NDT Pharmaceuticals | 7.51M |
| Zeo ScientifiX | 7.12M |